{"transactions":[{"id":779193,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-14T20:22:14.000Z","date":"2026-05-13","kind":"grant","planned":false,"acquired":true,"shares":5550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director."}],"balance_after":5550,"derivative":{"exercise_price":30.14,"exercise_date":"2027-05-13","expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":5550},"source":{"system":"sec-edgar","filing":"0001193125-26-224117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691868/000119312526224117/ownership.xml","form_type":"4"}},{"id":1147385,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-05-15T21:07:04.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director."}],"balance_after":1333,"derivative":{"exercise_price":6.5,"exercise_date":"2026-05-14","expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001593968-25-000607","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691868/000159396825000607/primary_01.xml","form_type":"4"}},{"id":1488466,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-06-07T00:14:39.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director."}],"balance_after":1333,"derivative":{"exercise_price":11,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001593968-24-000826","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691868/000159396824000826/primary_01.xml","form_type":"4"}},{"id":1838230,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-07-05T17:56:29.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":3264,"price":4.05,"value":13219.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2023 through June 30, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2023."}],"balance_after":113935,"source":{"system":"sec-edgar","filing":"0001415889-23-010828","document":"form4-07052023_090723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923010828/form4-07052023_090723.xml","form_type":"4"}},{"id":1882688,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-05-22T13:34:24.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options fully vest and become exercisable on the one-year anniversary of the grant date, subject to the reporting person's continuous service as a director."}],"balance_after":20000,"derivative":{"exercise_price":0.56,"exercise_date":"2023-06-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-23-023326","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691868/000095017023023326/ownership.xml","form_type":"4"}},{"id":2029514,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2023-02-07T17:22:18.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":63400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vest with respect to 40% of such RSUs on the one-year anniversary of the date of grant and with respect to the remaining 60% of such RSUs on the eighteen-month anniversary of the date of grant, subject to continued service through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs shall vest with respect to 40% of such RSUs on the one-year anniversary of the date of grant and with respect to the remaining 60% of such RSUs on the eighteen-month anniversary of the date of grant, subject to continued service through each vesting date."}],"balance_after":63400,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":63400},"source":{"system":"sec-edgar","filing":"0001415889-23-002106","document":"form4-02072023_100207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923002106/form4-02072023_100207.xml","form_type":"4"}},{"id":2029513,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-07T17:22:18.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":256300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant."}],"balance_after":256300,"derivative":{"exercise_price":4.66,"expiration_date":"2033-02-03","underlying":"Common Stock","underlying_shares":256300},"source":{"system":"sec-edgar","filing":"0001415889-23-002106","document":"form4-02072023_100207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923002106/form4-02072023_100207.xml","form_type":"4"}},{"id":2029512,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2023-02-07T17:22:18.000Z","date":"2023-02-03","kind":"grant","acquired":true,"shares":42700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date."}],"balance_after":42700,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":42700},"source":{"system":"sec-edgar","filing":"0001415889-23-002106","document":"form4-02072023_100207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923002106/form4-02072023_100207.xml","form_type":"4"}},{"id":2073566,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2023-01-03T17:21:31.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":436,"price":3.92,"value":1709.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from July\n  1, 2022 through December 31, 2022"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022"}],"balance_after":110671,"source":{"system":"sec-edgar","filing":"0001415889-23-000108","document":"form4-01032023_100110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923000108/form4-01032023_100110.xml","form_type":"4"}},{"id":2076348,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T17:13:08.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":222300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 7, 2020, the reporting person was granted an option to purchase 444,600 shares of common stock. The option vests in installments upon the satisfaction of certain performance criteria. On November 14, 2022, certain performance criteria were met, resulting in the vesting of 50% of the performance stock option award."}],"balance_after":333450,"derivative":{"exercise_price":4.55,"exercise_date":"2022-11-14","expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":222300},"source":{"system":"sec-edgar","filing":"0001415889-22-012990","document":"form4-12272022_101256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588922012990/form4-12272022_101256.xml","form_type":"4"}},{"id":2076347,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-27T17:13:08.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":111150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 7, 2020, the reporting person was granted an option to purchase 444,600 shares of common stock. The option vests in installments upon the satisfaction of certain performance criteria. On May 20, 2022, certain performance criteria were met, resulting in the vesting of 25% of the performance stock option award."}],"balance_after":111150,"derivative":{"exercise_price":4.55,"exercise_date":"2022-05-20","expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":111150},"source":{"system":"sec-edgar","filing":"0001415889-22-012990","document":"form4-12272022_101256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588922012990/form4-12272022_101256.xml","form_type":"4"}},{"id":2215873,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2022-07-05T16:31:19.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":3073,"price":3.825,"value":11754.225,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2022 through June 30, 2022"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022"}],"balance_after":110235,"source":{"system":"sec-edgar","filing":"0001415889-22-007332","document":"form4-07052022_010708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588922007332/form4-07052022_010708.xml","form_type":"4"}},{"id":2237795,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-06-09T21:48:28.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest and become exercisable on the one-year anniversary of the grant date, subject to the reporting person's continuous service as a director."}],"balance_after":20000,"derivative":{"exercise_price":2.79,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Surrozen, Inc. Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001593968-22-001108","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1691868/000159396822001108/primary_01.xml","form_type":"4"}},{"id":2409133,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-08T17:31:54.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":311700,"price":5.32,"value":1658244.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant."}],"balance_after":311700,"derivative":{"exercise_price":5.32,"exercise_date":"2023-02-04","expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":311700},"source":{"system":"sec-edgar","filing":"0001179110-22-000927","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911022000927/edgar.xml","form_type":"4"}},{"id":2452173,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-01-04T16:08:59.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":1761,"price":5.6,"value":9861.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from July 1, 2021 through December 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2021."}],"balance_after":107162,"source":{"system":"sec-edgar","filing":"0001179110-22-000106","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911022000106/edgar.xml","form_type":"4"}},{"id":2646303,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-02T16:22:24.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":2062,"price":5.52,"value":11382.24,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2021 through June 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 4, 2021."}],"balance_after":105401,"source":{"system":"sec-edgar","filing":"0001179110-21-007318","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911021007318/edgar.xml","form_type":"4"}},{"id":2873080,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock (right to buy)","published_at":"2021-02-09T20:09:41.000Z","date":"2021-02-05","kind":"grant","acquired":true,"shares":282019,"price":7.69,"value":2168726.11,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant."}],"balance_after":282019,"derivative":{"exercise_price":7.69,"exercise_date":"2022-02-05","expiration_date":"2031-02-05","underlying":"Common Stock","underlying_shares":282019},"source":{"system":"sec-edgar","filing":"0001179110-21-001492","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911021001492/edgar.xml","form_type":"4"}},{"id":2923522,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-01-05T08:58:55.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":2203,"price":4.04,"value":8900.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from July 1, 2020 through December 31, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2020."}],"balance_after":103339,"source":{"system":"sec-edgar","filing":"0001179110-21-000081","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911021000081/edgar.xml","form_type":"4"}},{"id":3093813,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-07-02T08:39:27.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":3047,"price":3.91,"value":11913.77,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from January 1, 2020 through June 30, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2020."}],"balance_after":101136,"source":{"system":"sec-edgar","filing":"0001179110-20-007818","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911020007818/edgar.xml","form_type":"4"}},{"id":3250758,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-25T08:37:45.000Z","date":"2020-02-24","kind":"sale","acquired":false,"shares":25803,"price":4.99,"value":128756.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of shares sold."}],"balance_after":98089,"source":{"system":"sec-edgar","filing":"0001179110-20-002185","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911020002185/edgar.xml","form_type":"4"}},{"id":3280578,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-11T09:25:49.000Z","date":"2020-02-07","kind":"grant","acquired":true,"shares":296400,"price":4.55,"value":1348620.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the options are exercisable on the first year anniversary of the grant and the balance is exercisable in twelve equal installments of 6.25%, quarterly over the following three years starting one quarter after the first year anniversary."}],"balance_after":296400,"derivative":{"exercise_price":4.55,"exercise_date":"2021-02-07","expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":296400},"source":{"system":"sec-edgar","filing":"0001179110-20-001426","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911020001426/edgar.xml","form_type":"4"}},{"id":3472982,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-07-02T13:40:01.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":5230,"price":1.84,"value":9623.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from January 1, 2019 through June 30, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2019."}],"balance_after":123892,"source":{"system":"sec-edgar","filing":"0001179110-19-008317","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019008317/edgar.xml","form_type":"4"}},{"id":3637077,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-02-25T10:10:51.000Z","date":"2018-02-22","kind":"sale","acquired":false,"shares":16562,"price":5.6,"value":92747.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of shares sold."}],"balance_after":118662,"source":{"system":"sec-edgar","filing":"0001179110-19-002468","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019002468/edgar.xml","form_type":"4"}},{"id":3678476,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-04T16:36:20.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":92500,"price":5.25,"value":485625.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exercisable in four equal installments over the next four years starting on the first year anniversary of the grant."}],"balance_after":92500,"derivative":{"exercise_price":5.25,"exercise_date":"2020-01-31","expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":92500},"source":{"system":"sec-edgar","filing":"0001179110-19-001230","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019001230/edgar.xml","form_type":"4"}},{"id":3678475,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-04T16:36:20.000Z","date":"2019-01-31","kind":"grant","acquired":true,"shares":256050,"price":5.25,"value":1344262.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable in three equal installments over the next three years starting on the first year anniversary of the grant."}],"balance_after":256050,"derivative":{"exercise_price":5.25,"exercise_date":"2020-01-31","expiration_date":"2029-01-31","underlying":"Common Stock","underlying_shares":256050},"source":{"system":"sec-edgar","filing":"0001179110-19-001230","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019001230/edgar.xml","form_type":"4"}},{"id":3706095,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-04T11:07:49.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":2455,"price":4.08,"value":10016.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (\"ESPP\"). It pertains to the ESPP purchase period from July 1, 2018 through December 31, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP; these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2018."}],"balance_after":135224,"source":{"system":"sec-edgar","filing":"0001179110-19-000356","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019000356/edgar.xml","form_type":"4"}},{"id":3789352,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-10-17T09:51:16.000Z","date":"2018-10-16","kind":"sale","acquired":false,"shares":5851,"price":8,"value":46808.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of shares sold."}],"balance_after":132769,"source":{"system":"sec-edgar","filing":"0001179110-18-012212","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018012212/edgar.xml","form_type":"4"}},{"id":3820090,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-11T17:20:02.000Z","date":"2018-09-10","kind":"sale","acquired":false,"shares":5851,"price":9.46,"value":55350.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of shares sold."}],"balance_after":138620,"source":{"system":"sec-edgar","filing":"0001179110-18-011292","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018011292/edgar.xml","form_type":"4"}},{"id":4038197,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-23T11:45:36.000Z","date":"2018-02-21","kind":"sale","acquired":false,"shares":17329,"price":10.88,"value":188539.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price of shares sold."}],"balance_after":144471,"source":{"system":"sec-edgar","filing":"0001179110-18-002672","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002672/edgar.xml","form_type":"4"}},{"id":4049535,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-20T16:02:42.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":175000,"price":10.65,"value":1863750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable in three equal installments over the next three years starting on the first year anniversary of the grant."}],"balance_after":175000,"derivative":{"exercise_price":10.65,"exercise_date":"2019-02-15","expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001179110-18-002365","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018002365/edgar.xml","form_type":"4"}},{"id":4207684,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-09-18T11:16:50.000Z","date":"2017-09-13","kind":"sale","acquired":false,"shares":1500,"price":7,"value":10500.0,"ownership":{"direct":true},"balance_after":161800,"source":{"system":"sec-edgar","filing":"0001179110-17-012351","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911017012351/edgar.xml","form_type":"4"}},{"id":4429240,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":47347,"kind":"person","name":"Berkenblit Anna","position":1,"cik":"0001691868","reported_name":"Berkenblit Anna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-23T15:21:14.000Z","date":"2017-02-21","kind":"grant","acquired":true,"shares":157300,"price":2.47,"value":388531.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are restricted stock which vest annually in three equal installments commencing on February 21, 2018."}],"balance_after":163300,"source":{"system":"sec-edgar","filing":"0001179110-17-003019","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911017003019/edgar.xml","form_type":"4"}}]}